European Archives of Psychiatry and Clinical Neuroscience

Papers
(The H4-Index of European Archives of Psychiatry and Clinical Neuroscience is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry125
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor87
Cognitive impairment in people with schizophrenia: an umbrella review81
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life76
Cognitive decline following acute viral infections: literature review and projections for post-COVID-1945
Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis43
Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions42
Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state41
Psychological and neuropsychiatric implications of COVID-1937
The German Guidelines for the treatment of anxiety disorders: first revision35
The role of microglia in neuropsychiatric disorders and suicide34
Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling31
One year after the COVID-19 outbreak in Germany: long-term changes in depression, anxiety, loneliness, distress and life satisfaction30
Limbic links to paranoia: increased resting-state functional connectivity between amygdala, hippocampus and orbitofrontal cortex in schizophrenia patients with paranoia29
P2X7R antagonists in chronic stress-based depression models: a review29
Social isolation and psychosis: an investigation of social interactions and paranoia in daily life28
Peripandemic psychiatric emergencies: impact of the COVID-19 pandemic on patients according to diagnostic subgroup28
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia26
Online therapy: an added value for inpatient routine care? Perspectives from mental health care professionals25
The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia25
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies24
Arketamine for cognitive impairment in psychiatric disorders22
0.029313087463379